BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24678898)

  • 1. Predictors of default from follow-up care in a cervical cancer screening program using direct visual inspection in south-western Nigeria.
    Ezechi OC; Petterson KO; Gbajabiamila TA; Idigbe IE; Kuyoro O; Ujah IA; Ostergren PO
    BMC Health Serv Res; 2014 Mar; 14():143. PubMed ID: 24678898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology.
    Sharp L; Cotton S; Thornton A; Gray N; Cruickshank M; Whynes D; Duncan I; Hammond R; Smart L; Little J
    Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):318-25. PubMed ID: 22921577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
    Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
    Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which women default from follow-up cervical cytology tests? A cohort study within the TOMBOLA trial.
    Sharp L; Cotton S; Thornton A; Gray N; Whynes D; Smart L; Waugh N; Duncan I; Cruickshank M; Little J;
    Cytopathology; 2012 Jun; 23(3):150-60. PubMed ID: 21366734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of precancerous lesions and other cervical abnormalities among internally displaced women in Benue State Nigeria.
    Ngwibete A; Ogunbode O; Swende LT; Agbada MM; Omigbodun A
    Pan Afr Med J; 2024; 47():50. PubMed ID: 38681110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer screening by visual inspection in Côte d'Ivoire, operational and clinical aspects according to HIV status.
    Horo A; Jaquet A; Ekouevi DK; Toure B; Coffie PA; Effi B; Messou E; Minga A; Moh R; Kone M; Dabis F; Sasco AJ;
    BMC Public Health; 2012 Mar; 12():237. PubMed ID: 22443255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.
    Swanson M; Ibrahim S; Blat C; Oketch S; Olwanda E; Maloba M; Huchko MJ
    BMC Womens Health; 2018 Jul; 18(1):116. PubMed ID: 29970063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Most women diagnosed with cervical cancer by a visual screening program in Tanzania completed treatment: evidence from a retrospective cohort study.
    Gard AC; Soliman AS; Ngoma T; Mwaiselage J; Kahesa C; Chamberlain RM; Harlow SD
    BMC Public Health; 2014 Sep; 14():910. PubMed ID: 25187329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare utilisation, cancer screening and potential barriers to accessing cancer care in rural South West Nigeria: a cross-sectional study.
    Sharma A; Alatise OI; O'Connell K; Ogunleye SG; Aderounmu AA; Samson ML; Wuraola F; Olasehinde O; Kingham TP; Du M
    BMJ Open; 2021 Jul; 11(7):e040352. PubMed ID: 34312189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.
    Mezei AK; Pedersen HN; Sy S; Regan C; Mitchell-Foster SM; Byamugisha J; Sekikubo M; Armstrong H; Rawat A; Singer J; Ogilvie GS; Kim JJ; Campos NG
    BMJ Open; 2018 Jun; 8(6):e020484. PubMed ID: 29895648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screen and Triage by Community Extension Workers to Facilitate Screen and Treat: Task-Sharing Strategy to Achieve Universal Coverage for Cervical Cancer Screening in Nigeria.
    Awolude OA; Oyerinde SO; Akinyemi JO
    J Glob Oncol; 2018 Jul; 4():1-10. PubMed ID: 30085882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motivations and preferences of rural Nigerian women undergoing cervical cancer screening via visual inspection with acetic acid.
    Chigbu CO; Onyebuchi AK; Ajah LO; Onwudiwe EN
    Int J Gynaecol Obstet; 2013 Mar; 120(3):262-5. PubMed ID: 23228820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of a community-based cervical cancer screening with "test and treat" strategy using self-sample for an HPV test: Experience from rural Cameroon, Africa.
    Fokom Domgue J; Futuh B; Ngalla C; Kakute P; Manjuh F; Manga S; Nulah K; Welty E; Schmeler K; Welty T
    Int J Cancer; 2020 Jul; 147(1):128-138. PubMed ID: 31633801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
    Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
    PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting cervical cancer screening uptake, visual inspection with acetic acid positivity and its predictors among women attending cervical cancer screening service in Addis Ababa, Ethiopia.
    Fentie AM; Tadesse TB; Gebretekle GB
    BMC Womens Health; 2020 Jul; 20(1):147. PubMed ID: 32677933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
    Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
    Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
    Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
    J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative evaluation of human papilloma virus-DNA test verses colposcopy as secondary cervical cancer screening test to triage screen positive women on primary screening by visual inspection with 5% acetic acid.
    Pimple S; Shastri SS
    Indian J Cancer; 2014; 51(2):117-23. PubMed ID: 25104191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer screening and treatment for PLWHIV: experiences from an innovative program in Nigeria.
    Ogunsola OO; Ajayi OA; Ojo TO; Osayi E; Wudiri K; Amoo B; Ayoka-Ikechukwu R; Olumeyan OO; Ifechelobi C; Okonkwo P; Akinro Y
    Reprod Health; 2023 Aug; 20(1):125. PubMed ID: 37633884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary health care workers' understanding and skills related to cervical cancer prevention in Sango PHC centre in south-western Nigeria: a qualitative study.
    Onyenwenyi AOC; Mchunu GG
    Prim Health Care Res Dev; 2019 Jul; 20():e93. PubMed ID: 32799996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.